Status:
COMPLETED
Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C
Lead Sponsor:
Bader, Ted, M.D.
Conditions:
Hepatitis C
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
Different Doses of rosuvastatin and atorvastatin will be used to see if HCV viral load changes and liver tests change.
Eligibility Criteria
Inclusion
- Hepatitis C
Exclusion
- HIV positivity
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2007
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00446940
Start Date
December 1 2006
End Date
March 1 2007
Last Update
September 9 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Hospital
Oklahoma City, Oklahoma, United States, 73104